The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Lomakin, Nikita V., Bakirov, Bulat A., Protsenko, Denis N., Mazurov, Vadim I., Musaev, Gaziyavdibir H., Moiseeva, Olga M., Pasechnik, Elena S., Popov, Vladimir V., Smolyarchuk, Elena A., Gordeev, Ivan G., Gilyarov, Mikhail Yu, Fomina, Darya S., Seleznev, Anton I., Linkova, Yulia N., Dokukina, Ekaterina A., Eremeeva, Anna V., Pukhtinskaia, Polina S., Morozova, Maria A., Zinkina-Orikhan, Arina V., Lutckii, Anton A.
Published in Inflammation research (01.12.2021)
Published in Inflammation research (01.12.2021)
Get full text
Journal Article
A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study
Lila, Alexander M., Mazurov, Vadim I., Denisov, Lev N., Nesmeyanova, Olga B., Ilivanova, Elena P., Eremeeva, Anna V., Usacheva, Julia Valentinovna, Dokukina, Ekaterina A., Chernyaeva, Ekaterina V., Ivanov, Roman A.
Published in Rheumatology international (01.09.2019)
Published in Rheumatology international (01.09.2019)
Get full text
Journal Article